REFRACTORY MERKEL CELL CARCINOMA
Clinical trials for REFRACTORY MERKEL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MERKEL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY MERKEL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough merkel cell cancer: drug combo targets DNA repair
Disease control OngoingThis study tests whether adding a drug called tuvusertib (which blocks a DNA repair enzyme) to the immunotherapy avelumab can slow down advanced Merkel cell cancer that has stopped responding to standard immunotherapy. About 50 adults with this rare skin cancer will be randomly a…
Matched conditions: REFRACTORY MERKEL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Cancer-killing virus plus immune booster shows promise for rare skin tumors
Disease control OngoingThis study tests a two-step treatment for people with rare skin cancers or certain lymphomas that haven't responded to standard care. First, patients receive a virus-based therapy (talimogene laherparepvec) that infects and kills tumor cells. Then, they also get an immunotherapy …
Matched conditions: REFRACTORY MERKEL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC